GEFITINIB TABLETS 250 MG
Treatment of adult patients with locally advanced or metastatic nonsmallcell lung cancer (NSCLC) with activating mutations of EGFRTK.
1 x 10 Alu PVC, 30’s Bottle
Note: Products are not marketed in countries where it is protected by Patent Law
Enter your name and email to download PDF.
Thanks, I’m not interested